Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorThe Lymphoma Academic Research Organisation

About this trial

Anaplastic large cell lymphoma associated with breast implants (BIA-ALCL) is a rare disease seen only in women with a breast implant.

Because of the low incidence of this disease and the peculiar histological subtype, French authorities, in accordance with the recommendations of an expert group, recommended the implementation of a BIA-ALCL case registry, in connection with a national Multidisciplinary meeting (Réunion de Concertation Pluridisciplinaire nationale de recours- RCP).

This registry is opened in France and in Belgium

Eligibility criteria

Qualifiers

Adult patients with an anaplastic large cell lymphoma associated with breast implants

Disqualifiers

None

Trial design

Treatments tested in this trial

  • BIA-ALCL

Treatment groups

150 Participants
are divided into 1 treatment group